BR0304716A - Método para formação de imagens de mri-bold on line, sensibilizada - Google Patents

Método para formação de imagens de mri-bold on line, sensibilizada

Info

Publication number
BR0304716A
BR0304716A BR0304716-4A BR0304716A BR0304716A BR 0304716 A BR0304716 A BR 0304716A BR 0304716 A BR0304716 A BR 0304716A BR 0304716 A BR0304716 A BR 0304716A
Authority
BR
Brazil
Prior art keywords
bold
time
mri
generating
patient
Prior art date
Application number
BR0304716-4A
Other languages
English (en)
Inventor
Yoram Salomon
Michal Neeman
Avigdor Scherz
Shimon Gross
Assaf Gilead
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of BR0304716A publication Critical patent/BR0304716A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/4806—Functional imaging of brain activation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MéTODO PARA FORMAçãO DE IMAGENS DE MRI-BOLD ON LINE, SENSIBILIZADA". Método de reprodução de imagens on line por ressonância magnética (MRI), Dependente do Nível de Oxigenação do Sangue (BOLD), para guia ou monitoração clínica funcional de uma modalidade terapêutica, que envolve tratamento por um sensibilizante que, sob excitação pela radiação sensibilizante apropriada, inicia o consumo de oxigênio local, que compreende: (i) gerar uma imagem de MR ponderada por BOLD da região de interesse visada dentro do corpo do paciente (tempo t~ 0~); (ii) administrar o referido sensibilizante ao paciente; (iii) irradiar a região visada, enquanto o paciente é submetido à reprodução de imagem de MR contínua; (iv) gerar uma única imagem ou uma pluralidade de imagens de MR de BOLD seq³enciais ponderadas com T2^ *^ durante e/ou após a irradiação (tempo t); (v) processar os dados gerados no tempo t~ 0~ e no tempo t e gerar um mapa de diferença ou relação codificado por cores, em uma base de pixel por pixel; e (vi) analisar os dados processados. O método é preferivelmente aplicado à terapia fotodinâmica (PDT).
BR0304716-4A 2002-05-08 2003-05-08 Método para formação de imagens de mri-bold on line, sensibilizada BR0304716A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37840902P 2002-05-08 2002-05-08
PCT/IL2003/000371 WO2003094695A2 (en) 2002-05-08 2003-05-08 Sensitized online bold-mri imaging method

Publications (1)

Publication Number Publication Date
BR0304716A true BR0304716A (pt) 2004-07-13

Family

ID=29420397

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0304716-4A BR0304716A (pt) 2002-05-08 2003-05-08 Método para formação de imagens de mri-bold on line, sensibilizada

Country Status (10)

Country Link
US (1) US7715901B2 (pt)
EP (2) EP1509129A4 (pt)
JP (1) JP2005524461A (pt)
AU (1) AU2003230164B2 (pt)
BR (1) BR0304716A (pt)
CA (1) CA2485224A1 (pt)
IL (1) IL164999A (pt)
NO (1) NO20040042L (pt)
RU (1) RU2343829C2 (pt)
WO (1) WO2003094695A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005079661A1 (ja) 2004-02-24 2005-09-01 Waseda University 表在性化学種測定方法および測定装置
EP1753457B8 (en) 2004-06-07 2016-09-21 Yeda Research And Development Co., Ltd. Cationic bacteriochlorophyll derivatives and uses thereof
US8315450B2 (en) * 2004-11-24 2012-11-20 Wisconsin Alumni Research Foundation Method and system for display of medical image data
AU2006214202A1 (en) * 2005-02-17 2006-08-24 Light Sciences Oncology, Inc. Photoreactive system and methods for prophylactic treatment of atherosclerosis
US7636420B2 (en) 2005-05-26 2009-12-22 Koninklijke Philips Electronics N.V. Radio-therapeutic treatment planning incorporating functional imaging information
RU2466679C2 (ru) * 2006-11-30 2012-11-20 Конинклейке Филипс Электроникс Н.В. Визуализация сосудистой структуры
JP4966640B2 (ja) * 2006-12-18 2012-07-04 学校法人慶應義塾 光線力学的治療装置およびその使用方法
WO2010082944A2 (en) * 2008-02-29 2010-07-22 The Regents Of The University Of Michigan Systems and methods for imaging changes in tissue
EP2340441A1 (en) * 2008-10-13 2011-07-06 Koninklijke Philips Electronics N.V. Flow insensitive magnetization preparation pulse for t2* contrast
US8571634B2 (en) * 2010-07-23 2013-10-29 David R. Hubbard Method to diagnose and measure vascular drainage insufficiency in the central nervous system
EP2425873A1 (fr) * 2010-09-07 2012-03-07 Steba Maor SA Modélisation de l'action d'une fibre optique dans un traitement par therapie photodynamique, et assistance à la planification d'un tel traitement
FI20115306L (fi) 2011-03-31 2012-10-01 Valkee Oy Valon annostelulaite
US20120278380A1 (en) * 2011-04-29 2012-11-01 Joseph Curran Outdoor Tracker System with Visual Communication Devices
EP2745240A2 (en) * 2011-09-29 2014-06-25 Koninklijke Philips N.V. Distortion reduced signal detection
US9480402B2 (en) 2011-11-11 2016-11-01 Washington University System and method for task-less mapping of brain activity
CN104981255B (zh) * 2012-12-11 2018-11-30 国立大学法人熊本大学 核磁共振诊断剂以及使用所述核磁共振诊断剂来检测或诊断对象中细胞、组织或器官状态的方法
CN103914697B (zh) * 2012-12-29 2018-08-31 上海联影医疗科技有限公司 一种乳房三维图像感兴趣区域的提取方法
CN103927732B (zh) * 2013-01-11 2016-03-30 上海联影医疗科技有限公司 一种胸壁线的检测方法
US9125606B2 (en) * 2013-03-13 2015-09-08 Koninklijke Philips N.V. Device and method for determining the blood oxygen saturation of a subject
US10426388B2 (en) 2014-01-31 2019-10-01 The General Hospital Corporation Prediction of tumor recurrence by measuring oxygen saturation
US20220183561A1 (en) * 2019-04-11 2022-06-16 The General Hospital Corporation Generating imaging-based neurological state biomarkers and estimating cerebrospinal fluid (csf) dynamics based on coupled neural and csf oscillations during sleep
US11443429B2 (en) 2019-05-30 2022-09-13 Washington University Atlas registration for resting state network mapping in patients with brain tumors
CN111035612B (zh) * 2019-12-31 2020-12-18 华中科技大学 一种活性氧响应性凝胶贮库及其制备方法与应用
CN116376033B (zh) * 2023-03-03 2024-01-16 广州市第一人民医院（广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院） 一种活性氧响应的自激活骨架聚合物及其制备方法和应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5190966A (en) * 1988-07-06 1993-03-02 Health Research, Inc. Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
US5177073A (en) * 1988-09-30 1993-01-05 Baylor Research Institute Therapeutic compositions derived from photoactive compounds
US5298502A (en) * 1988-12-12 1994-03-29 Fmc Corporation Method and composition for photodynamic treatment and detection of tumors
US5162509A (en) * 1989-03-06 1992-11-10 Board Of Regents, The University Of Texas System Process for preparing expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5159065A (en) * 1989-12-21 1992-10-27 Board Of Regents, The University Of Texas System Sapphyrins, derivatives and syntheses
US5214036A (en) * 1990-03-08 1993-05-25 University Of British Columbia Benzoporphyrin derivatives for photodynamic therapy
US5189029A (en) * 1990-04-23 1993-02-23 Bo-Dekk Ventures, Ltd. Indacene compounds and methods for using the same
US5166197A (en) * 1990-07-17 1992-11-24 Kenney Malcolm E Phthalocyanine photosensitizers for photodynamic therapy
US6196226B1 (en) * 1990-08-10 2001-03-06 University Of Washington Methods and apparatus for optically imaging neuronal tissue and activity
US5244671A (en) * 1991-01-29 1993-09-14 Cytopharm, Inc. Derivatives of porphycene for photodynamic therapy of cancer
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
US5277913A (en) * 1991-09-09 1994-01-11 Thompson David H Liposomal delivery system with photoactivatable triggered release
US5261874A (en) * 1991-09-16 1993-11-16 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Extra-corporeal blood access, sensing, and radiation methods and apparatuses
US5888997A (en) * 1994-04-14 1999-03-30 Pharmacyclics, Inc. Radiation sensitization using texaphyrins
IL102645A (en) 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
US6147195A (en) 1993-07-26 2000-11-14 Yeda Research And Development Co., Ltd. Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
IL116126A0 (en) 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them
US6022959A (en) * 1996-08-20 2000-02-08 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6493570B1 (en) * 1998-11-02 2002-12-10 Photogen, Inc. Method for improved imaging and photodynamic therapy
US6321105B1 (en) * 1998-04-08 2001-11-20 Bracco S.P.A. Method for diagnosing neurological, neurodegenerative and psychiatric diseases by magnetic resonance imaging using contrast agents with high magnetic susceptibility and extended plasma half life
US6364845B1 (en) * 1998-09-17 2002-04-02 University Of Rochester Methods for diagnosing visuospatial disorientation or assessing visuospatial orientation capacity
JP4796227B2 (ja) 1998-12-09 2011-10-19 イエダ・リサーチ・アンド・デベロツプメント・カンパニー・リミテツド パラジウム置換バクテリオクロロフィル誘導体およびその用途
US6162242A (en) * 1999-01-21 2000-12-19 Peyman; Gholam A. Selective photodynamic treatment
US7108982B1 (en) * 1999-02-19 2006-09-19 University Of Iowa Research Foundation Diagnostics and the therapeutics for macular degeneration
AU1547101A (en) * 1999-11-26 2001-06-04 Applied Spectral Imaging Ltd. System and method for functional brain mapping and an oxygen saturation difference map algorithm for effecting same
IL133253A0 (en) 1999-12-01 2001-04-30 Yeda Res & Dev Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
AU2002218742A1 (en) * 2000-07-11 2002-01-21 Johns Hopkins University Application of photochemotherapy for the treatment of cardiac arrhythmias
US6567684B1 (en) * 2000-11-08 2003-05-20 Regents Of The University Of Michigan Imaging system, computer, program product and method for detecting changes in rates of water diffusion in a tissue using magnetic resonance imaging (MRI)
WO2002061457A2 (en) * 2001-01-30 2002-08-08 Decharms R Christopher Methods for physiological monitoring, training, exercise and regulation
WO2002068930A2 (en) * 2001-02-23 2002-09-06 Allos Therapeutics, Inc. Methods and reagents to acquire mri signals and images

Also Published As

Publication number Publication date
US20060135868A1 (en) 2006-06-22
CA2485224A1 (en) 2003-11-20
NO20040042L (no) 2004-03-05
AU2003230164A1 (en) 2003-11-11
EP1509129A4 (en) 2009-03-25
AU2003230164B2 (en) 2008-05-01
EP2401962A1 (en) 2012-01-04
IL164999A (en) 2010-12-30
RU2004135823A (ru) 2005-05-10
WO2003094695A3 (en) 2004-03-18
WO2003094695A2 (en) 2003-11-20
RU2343829C2 (ru) 2009-01-20
JP2005524461A (ja) 2005-08-18
IL164999A0 (en) 2005-12-18
US7715901B2 (en) 2010-05-11
EP1509129A2 (en) 2005-03-02

Similar Documents

Publication Publication Date Title
BR0304716A (pt) Método para formação de imagens de mri-bold on line, sensibilizada
Bookheimer et al. Activation of language cortex with automatic speech tasks
BR9914969A (pt) Métodos para formar imagem, tratar e localizar tecido doente, e, dispositivo integrado de formação de imagem e de tratamento
Balter et al. Improvement of CT-based treatment-planning models of abdominal targets using static exhale imaging
Olzowy et al. Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid
Rössler et al. Evaluation of preoperative high magnetic field motor functional MRI (3 Tesla) in glioma patients by navigated electrocortical stimulation and postoperative outcome
Boscolo Galazzo et al. Patient-specific detection of cerebral blood flow alterations as assessed by arterial spin labeling in drug-resistant epileptic patients
Haider et al. Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide
Paquette et al. Bilateral transcranial direct current stimulation modulates activation-induced regional blood flow changes during voluntary movement
Kaplan et al. Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors
Usenius et al. Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo
Li et al. Cerebral functional reorganization in ischemic stroke after repetitive transcranial magnetic stimulation: an fMRI study
Gabriel et al. Blood oxygen level dependent functional magnetic resonance imaging for presurgical planning
Li et al. Preliminary evaluation of a novel thermoplastic mask system with intra-fraction motion monitoring for future use with image-guided gamma knife
Murray Equine MRI
Bosma et al. Spinal cord response to stepwise and block presentation of thermal stimuli: A functional MRI study
Ito et al. Oedema formation in experimental photo-irradiation therapy of brain tumours using 5-ALA
Fisher et al. Modulation of PPIX synthesis and accumulation in various normal and glioma cell lines by modification of the cellular signaling and temperature
WO2014128147A1 (en) Hyperthermia for diagnostic imaging
JP2009006145A (ja) 患者の脳の標的領域への接近通路を求めて表示する方法、コンピュータプログラム製品、データ媒体および画像化装置
Vasileiadi et al. Functional connectivity explains how neuronavigated TMS of posterior temporal subregions differentially affect language processing
Straub et al. Mask-adapted background field removal for artifact reduction in quantitative susceptibility mapping of the prostate
Votaw et al. A confrontational naming task produces congruent increases and decreases in PET and fMRI
Voelker et al. Evaluating an approach to improving attention networks by theta stimulation
Stark et al. 5‐HT2C antagonism blocks blood oxygen level‐dependent pharmacological‐challenge magnetic resonance imaging signal in rat brain areas related to feeding

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A(S) 7A E 8A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011.